je.st
news
SC high court further reduces penalty in drug marketing case
2015-07-08 19:22:30| Biotech - Topix.net
South Carolina's highest court on Wednesday further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. In its ruling, the state Supreme Court ordered Janssen Pharmaceutica, Inc., to pay about $124 million - more than $200 million less than the original penalty amount.
Tags: high
case
marketing
court
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|